The FDA declared the end to shortages of Zepbound and Mounjaro. That could mean new restrictions on pharmacies making ...

The Food and Drug Administration declared an end to the scarcity of Eli Lilly's highly in-demand weight-loss and diabetes ...

The San Francisco telehealth company had capitalized on the shortage by making copycat versions of popular brand-name GLP-1 ...

Telehealth companies and patients are grappling with the potential loss of access to cheaper, alternative versions of Eli ...

Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...

Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...

Eli Lilly and Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, ...

Altimmune, Inc.'s weight loss drug pemvidutide shows promise as a takeover target with superior lean mass retention and maybe ...

In this article, we will discuss: 12 Best Growth Stocks To Buy According To Hedge Funds.

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...